undefined undefined
NaN.000
NaN.00%
Collegium Pharmaceutical (NASDAQ:COLL) on Monday entered into an agreement with Jefferies to repurchase $35 million of the company’s common stock. Collegium said it will execute the accelerated share ...
05-13 21:06
Collegium Pharmaceutical (NASDAQ:COLL) has been downgraded to neutral by Piper Sandler over valuation. Piper Sandler said in a note released Thursday that shares had risen around 64% over the past 12 ...
05-11 01:12
Needham analyst Serge Belanger downgrades Collegium Pharmaceutical (NASDAQ:COLL) from Buy to Hold.
05-10 19:43
Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $1.45 per share which beat the analyst consensus estimate of $0.73 by 98.63 percent. This is a 9.85 percent increase over earnings of $1.32 per share
05-10 04:46
Collegium Pharmaceutical (NASDAQ:COLL) announced that effective May 24, 2024, Joe Ciaffoni will step down as President and Chief Executive Officer of the company. Ciaffoni will serve as a member of th...
05-10 04:29
Club Crisps flavored with Mike's Hot Honey bring the heat for a next-level snacking experience, available for a limited time starting in May CHICAGO, May 7, 2024 /PRNewswire/ -- Sweet and sp...
05-07 21:00
新世界發展(00017.HK)與遠東發展(00035.HK)合作發展啟德跑道區承景街項目正式命名為「柏蔚森 The Pavilia Forest」。項目屬 「...
05-02 15:40
Collegium Pharmaceutical, Inc. (NASDAQ:COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced it has entered into
04-29 20:22
Donation to support training and apprenticeship programs for growing regional industries CHARLOTTE, N.C., April 17, 2024 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in...
04-17 18:50
Collegium Pharmaceutical (NASDAQ:COLL) on Thursday announced that it has called all $26.35M aggregate principal amount of its outstanding 2.625% convertible senior notes due 2026 for redemption on Jun...
04-11 20:53